Eric C. Bielefeld

1.3k total citations
43 papers, 1.0k citations indexed

About

Eric C. Bielefeld is a scholar working on Sensory Systems, Cognitive Neuroscience and Neurology. According to data from OpenAlex, Eric C. Bielefeld has authored 43 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Sensory Systems, 21 papers in Cognitive Neuroscience and 12 papers in Neurology. Recurrent topics in Eric C. Bielefeld's work include Hearing, Cochlea, Tinnitus, Genetics (36 papers), Hearing Loss and Rehabilitation (20 papers) and Vestibular and auditory disorders (12 papers). Eric C. Bielefeld is often cited by papers focused on Hearing, Cochlea, Tinnitus, Genetics (36 papers), Hearing Loss and Rehabilitation (20 papers) and Vestibular and auditory disorders (12 papers). Eric C. Bielefeld collaborates with scholars based in United States, China and Italy. Eric C. Bielefeld's co-authors include Donald Henderson, Richard D. Kopke, John K.M. Coleman, Ronald L. Jackson, Chiemi Tanaka, Guang‐Di Chen, Jianzhong Liu, Bo Hua Hu, Manna Li and Jianzhong Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of the Acoustical Society of America and Antioxidants and Redox Signaling.

In The Last Decade

Eric C. Bielefeld

43 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric C. Bielefeld United States 18 830 426 336 230 152 43 1.0k
Jean‐Paul Erre France 21 796 1.0× 426 1.0× 407 1.2× 96 0.4× 141 0.9× 33 1.1k
Josef M. Miller United States 10 519 0.6× 215 0.5× 190 0.6× 128 0.6× 117 0.8× 10 665
Pablo Gil‐Loyzaga Spain 19 707 0.9× 282 0.7× 213 0.6× 58 0.3× 206 1.4× 76 1.2k
Elżbieta Rajkowska Poland 15 356 0.4× 189 0.4× 78 0.2× 203 0.9× 133 0.9× 23 869
Meiyan Jiang China 12 222 0.3× 122 0.3× 124 0.4× 17 0.1× 172 1.1× 23 670
Michel Marot France 9 344 0.4× 105 0.2× 89 0.3× 14 0.1× 114 0.8× 10 511
Narinobu Harada Japan 14 250 0.3× 35 0.1× 104 0.3× 7 0.0× 104 0.7× 28 412
Kevin Rowland United States 12 201 0.2× 236 0.6× 32 0.1× 7 0.0× 323 2.1× 23 861
Yuzo Murata Japan 15 81 0.1× 98 0.2× 32 0.1× 34 0.1× 220 1.4× 36 847
Mary Ford United States 5 177 0.2× 33 0.1× 37 0.1× 3 0.0× 58 0.4× 5 392

Countries citing papers authored by Eric C. Bielefeld

Since Specialization
Citations

This map shows the geographic impact of Eric C. Bielefeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric C. Bielefeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric C. Bielefeld more than expected).

Fields of papers citing papers by Eric C. Bielefeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric C. Bielefeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric C. Bielefeld. The network helps show where Eric C. Bielefeld may publish in the future.

Co-authorship network of co-authors of Eric C. Bielefeld

This figure shows the co-authorship network connecting the top 25 collaborators of Eric C. Bielefeld. A scholar is included among the top collaborators of Eric C. Bielefeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric C. Bielefeld. Eric C. Bielefeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bielefeld, Eric C., et al.. (2024). Gene therapy advancements for the treatment of acquired and hereditary hearing loss. SHILAP Revista de lepidopterología. 2. 2 indexed citations
2.
Bielefeld, Eric C., et al.. (2021). Cochlear Preconditioning as a Modulator of Susceptibility to Hearing Loss. Antioxidants and Redox Signaling. 36(16-18). 1215–1228. 2 indexed citations
3.
Bielefeld, Eric C., et al.. (2021). Early Physiological and Cellular Indicators of Cisplatin-Induced Ototoxicity. Journal of the Association for Research in Otolaryngology. 22(2). 107–126. 12 indexed citations
4.
Bielefeld, Eric C., et al.. (2021). Changing the time intervals between cisplatin cycles alter its ototoxic side effect. Hearing Research. 404. 108204–108204. 2 indexed citations
5.
Bielefeld, Eric C., et al.. (2019). Advances and Challenges in Pharmaceutical Therapies to Prevent and Repair Cochlear Injuries From Noise. Frontiers in Cellular Neuroscience. 13. 285–285. 8 indexed citations
6.
Yu, Yan, Bing Hu, Jianxin Bao, et al.. (2018). Otoprotective Effects of Stephania tetrandra S. Moore Herb Isolate against Acoustic Trauma. Journal of the Association for Research in Otolaryngology. 19(6). 653–668. 10 indexed citations
7.
Gombash, Sara E., Christopher Cowley, Julie C. Fitzgerald, et al.. (2017). Systemic gene delivery transduces the enteric nervous system of guinea pigs and cynomolgus macaques. Gene Therapy. 24(10). 640–648. 18 indexed citations
8.
Bielefeld, Eric C., et al.. (2016). Ototoxicity of 12 mg/kg cisplatin in the Fischer 344/NHsd rat using multiple dosing strategies. Anti-Cancer Drugs. 27(8). 780–786. 11 indexed citations
9.
Bielefeld, Eric C., et al.. (2016). Long-Term Synergistic Interaction of Cisplatin- and Noise-Induced Hearing Losses. Ear and Hearing. 38(3). 282–291. 12 indexed citations
10.
Bielefeld, Eric C.. (2015). Protection from noise-induced hearing loss with Src inhibitors. Drug Discovery Today. 20(6). 760–765. 8 indexed citations
11.
Bielefeld, Eric C., Chiemi Tanaka, Donald Coling, et al.. (2012). An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect. Anti-Cancer Drugs. 24(1). 43–51. 22 indexed citations
12.
Bielefeld, Eric C., David Hangauer, & Donald Henderson. (2011). Protection from impulse noise-induced hearing loss with novel Src-protein tyrosine kinase inhibitors. Neuroscience Research. 71(4). 348–354. 12 indexed citations
13.
Bielefeld, Eric C., et al.. (2009). Age-related hearing loss: Is it a preventable condition?. Hearing Research. 264(1-2). 98–107. 82 indexed citations
14.
Tanaka, Chiemi, Eric C. Bielefeld, Guang‐Di Chen, Manna Li, & Donald Henderson. (2009). Ameliorative effects of an augmented acoustic environment on age‐related hearing loss in middle‐aged Fischer 344/NHsd rats. The Laryngoscope. 119(7). 1374–1379. 17 indexed citations
15.
Chen, Guang‐Di, Manna Li, Chiemi Tanaka, et al.. (2008). Aging outer hair cells (OHCs) in the Fischer 344 rat cochlea: Function and morphology. Hearing Research. 248(1-2). 39–47. 50 indexed citations
16.
Yang, Wei, et al.. (2008). Protective effect of N-acetyl-L-cysteine (L-NAC) against styrene-induced cochlear injuries. Acta Oto-Laryngologica. 129(10). 1036–1043. 14 indexed citations
17.
Bielefeld, Eric C., Donald Coling, Guang‐Di Chen, & Donald Henderson. (2008). Multiple dosing strategies with acetyl L-carnitine (ALCAR) fail to alter age-related hearing loss in the Fischer 344/NHsd rat. Journal of Negative Results in BioMedicine. 7(1). 4–4. 28 indexed citations
18.
Harris, Kelly C., Eric C. Bielefeld, Bo Hua Hu, & Donald Henderson. (2006). Increased resistance to free radical damage induced by low-level sound conditioning. Hearing Research. 213(1-2). 118–129. 26 indexed citations
19.
Hu, Bo Hua, Donald Henderson, Eric C. Bielefeld, et al.. (2006). WITHDRAWN: Prevention of hearing loss from noise exposure using Src inhibitors. Hearing Research. 1 indexed citations
20.
Kopke, Richard D., Eric C. Bielefeld, Jianzhong Liu, et al.. (2004). Prevention of impulse noise-induced hearing loss with antioxidants. Acta Oto-Laryngologica. 125(3). 235–243. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Paul Erre Breakdown of academic impact, for papers by Josef M. Miller Breakdown of academic impact, for papers by Pablo Gil‐Loyzaga Breakdown of academic impact, for papers by Elżbieta Rajkowska Breakdown of academic impact, for papers by Meiyan Jiang Breakdown of academic impact, for papers by Michel Marot Breakdown of academic impact, for papers by Narinobu Harada Breakdown of academic impact, for papers by Kevin Rowland Breakdown of academic impact, for papers by Yuzo Murata Breakdown of academic impact, for papers by Mary Ford
Rankless by CCL
2026